# Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma

> **NCT00179881** · PHASE2 · COMPLETED · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago** · enrollment: 47 (estimated)

## Conditions studied

- Brain Stem Neoplasms, Primary
- Neoplasms, Brain Stem

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Thalomid
- **PROCEDURE:** External Beam Radiation Therapy

## Key facts

- **NCT ID:** NCT00179881
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 47 (ESTIMATED)
- **Last updated:** 2019-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179881, "Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00179881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*